Perrigo Company plc (PRGO)

Market Cap	2.97B
Revenue (ttm)	4.33B
Net Income (ttm)	-80.20M
Shares Out	137.58M
EPS (ttm)	-0.58
PE Ratio	n/a
Forward PE	6.94
Dividend	$1.16 (5.37%)
Ex-Dividend Date	Aug 29, 2025

Volume	1,649,985
Open	21.84
Previous Close	21.94
Day's Range	21.29 - 21.84
52-Week Range	20.52 - 30.93
Beta	0.43
Analysts	Buy
Price Target	31.25 (+44.68%)
Earnings Date	Nov 5, 2025

About PRGO

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain rel...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Dec 16, 1991
• Employees: 8,379
• Stock Exchange: NYSE
• Ticker Symbol: PRGO
• Website: https://www.perrigo.com

Financial Performance

In 2024, Perrigo Company's revenue was $4.37 billion, a decrease of -6.06% compared to the previous year's $4.66 billion. Losses were -$171.80 million, 1252.8% more than in 2023.

Analyst Summary

According to 4 analysts, the average rating for PRGO stock is "Buy." The 12-month stock price target is $31.25, which is an increase of 44.68% from the latest price.

Price Target

$31.25

(44.68% upside)

Analyst Consensus: Buy